| 초록 |
Renal tubulointerstitial fibrosis is considered as the final outcome of progressive chronic kidney diseases and is closely
associated with peritubular inflammation; however, the exact molecular mechanisms involved in peritubular inflammation-
mediated renal fibrosis are still not elusive. We assessed here the role of ATF3 on streptozotocine-induced
diabetic kidney failure and especially, signaling of inflammatory factors and macrophage infiltration during the processing
of fibrosis. STZ-injected rats exhibited renal dysfunction, as evidenced by increased volume of renal glomerulus,
thickened basement membrane, and increased mesenterium mass. ATF3 and MCP-1 expression was correlatively
increased in kidney tissue of STZ-injected rats, which is associated with the activation of macrophage infiltration and
ECM accumulation. In NRK-52E cells, TNF-α-induced fibrotic gene expression was potentiated by ATF3, which were
attenuated by ATF3 siRNA. Also, ATF3 determined TNF-α-induced activation of NF-κB, which subsequently led to
increase the expression of several inflammation-related proteins, such as MCP-1, ICAM-1, VCAM-1. The critical roles
of ATF3 on the regulation of NF-κB-dependent MCP-1 expression were confirmed by performing luciferase assay
using wild-type or mutated MCP-1 promoter constructs. TNF-α-induced transcriptional activation of MCP-1 and their
potentiation by ATF3 were detected only in the cells transfected with pMCP-1-514 (enh), which contains two copy
of NF-kB binding sites, but not in pMCP-1-514(enh)mutA or pMCP-1-514(enh)mutB-transfected cells. The macrophage
cells cocultured in upper chamber were migrated into the TNF-α treated NRK-52E cells of lower chamber, which
were abolished by ATF3 depletion or anti-TNF-α antibody. Here, we know that ATF3 may play as an important
regulator of renal fibrosis by enhancing ECM accumulation and macrophage infiltration, and thereby reveals a new
aspect of the therapeutic mechanisms involved in DN. |